TELA Bio, Inc.
TELA
$1.69
-$0.05-2.87%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 75.32M | 71.22M | 69.30M | 68.65M | 64.74M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 75.32M | 71.22M | 69.30M | 68.65M | 64.74M |
| Cost of Revenue | 24.25M | 23.17M | 22.43M | 21.38M | 19.94M |
| Gross Profit | 51.08M | 48.04M | 46.87M | 47.27M | 44.80M |
| SG&A Expenses | 79.13M | 78.47M | 79.37M | 83.04M | 81.09M |
| Depreciation & Amortization | 380.00K | 380.00K | 380.00K | 380.00K | 380.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 112.60M | 110.98M | 111.00M | 114.27M | 111.18M |
| Operating Income | -37.27M | -39.76M | -41.70M | -45.62M | -46.44M |
| Income Before Tax | -40.83M | -43.54M | -37.99M | -41.52M | -42.11M |
| Income Tax Expenses | -59.00K | -92.00K | -144.00K | -- | -- |
| Earnings from Continuing Operations | -40.77 | -43.44 | -37.84 | -41.52 | -42.11 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -40.77M | -43.44M | -37.84M | -41.52M | -42.11M |
| EBIT | -37.27M | -39.76M | -41.70M | -45.62M | -46.44M |
| EBITDA | -36.21M | -38.72M | -40.68M | -44.71M | -45.57M |
| EPS Basic | -1.12 | -1.41 | -1.39 | -1.69 | -1.72 |
| Normalized Basic EPS | -0.70 | -0.88 | -1.06 | -1.25 | -1.26 |
| EPS Diluted | -1.12 | -1.41 | -1.39 | -1.69 | -1.72 |
| Normalized Diluted EPS | -0.70 | -0.88 | -1.06 | -1.25 | -1.26 |
| Average Basic Shares Outstanding | 155.41M | 134.71M | 114.02M | 98.44M | 98.22M |
| Average Diluted Shares Outstanding | 155.41M | 134.71M | 114.02M | 98.44M | 98.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |